DOP10: Early intestinal resection in Crohn’s Disease is not associated with severe long-term disease courseECCO’23 Copenhagen 2023
DOP11: A novel diagnostic serum protein signature for paediatric Inflammatory Bowel Disease: A discovery and validation study in two independent inception cohortsECCO’23 Copenhagen 2023
DOP12: Validation of radiomics features on MR enterography characterizing inflammation and fibrosis in stricturing Crohn’s diseaseECCO’23 Copenhagen 2023
DOP13: Plasma metabolite fingerprint could discriminate inflammatory bowel disease patients from healthy subjectsECCO’23 Copenhagen 2023
DOP14: Identification and validation of a lipidomic signature as a novel diagnostic biomarker of paediatric Inflammatory Bowel DiseaseECCO’23 Copenhagen 2023
DOP15: Intestinal ultrasound correlates with colonoscopy and biomarkers, and can be used in a tight monitoring approach to assess response to therapy in Crohn's disease: a multicentre prospective studyECCO’23 Copenhagen 2023
DOP16: Anti-integrin ⍺vβ6 autoantibodies predate Ulcerative Colitis diagnosis by up to 10 years and are associated with adverse disease-related outcomesECCO’23 Copenhagen 2023
DOP17: HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study based on the ENEIDA registry.ECCO’23 Copenhagen 2023
DOP18: Brain structural correlates of fatigue in active and quiescent Crohn’s DiseaseECCO’23 Copenhagen 2023
DOP19: Incidence and initial disease presentation of inflammatory bowel diseases in Denmark: findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)ECCO’23 Copenhagen 2023
DOP20: The impact of early life antibiotics on the occurrence of paediatric inflammatory bowel disease - a nationwide study from 1995 – 2018ECCO’23 Copenhagen 2023
DOP21: Disease activity patterns of paediatric Inflammatory Bowel Disease – A Danish nationwide cohort study 1996-2018ECCO’23 Copenhagen 2023
DOP22: Antibiotic Use as a Risk Factor for Inflammatory Bowel Disease Across the Ages: A Population-Based Cohort StudyECCO’23 Copenhagen 2023
DOP23: Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST surveyECCO’23 Copenhagen 2023
DOP24: Early life exposures and risk for inflammatory bowel disease: a nested case-control study in Quebec, CanadaECCO’23 Copenhagen 2023
DOP25: Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United StatesECCO’23 Copenhagen 2023
DOP27: Disease activity patterns in the first 5 years after diagnosis in children with Crohn’s disease: a population-based study.ECCO’23 Copenhagen 2023
DOP28: Aconitate decarboxylase 1 (ACOD1) represents a crucial regulator of monocyte recruitment, survival and proinflammatory status in intestinal inflammationECCO’23 Copenhagen 2023
DOP29: Single cell analysis of Crohn’s disease fistula; comparison of different locationsECCO’23 Copenhagen 2023